Therapy Areas: Respiratory
INOVIO's INO-3107 Biologics License Application accepted by US FDA
30 December 2025 - Biotechnology company INOVIO (NASDAQ:INO) announced on Monday that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for INO-3107 for re...
Italfarmaco and JCR PHarmaceuticals strike Japan deal for givinostat and expand rare disease collaboration
24 December 2025 - Pharmaceutical companies Italfarmaco S.p.A. and JCR Pharmaceuticals Co, Ltd (TSE 4552) on Wednesday announced an exclusive licensing agreement granting JCR Pharmaceuticals rights to...
Sanofi and Regeneron's Dupixent gains Japan approval for paediatric asthma patients aged 6 to 11
23 December 2025 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) and US biotechnology company Regeneron Pharmaceuticals Inc (Nasdaq:REGN) on Tuesday announced approval from J...
Aqualung Therapeutics' Phase 2a lung fibrosis study approved by US FDA
23 December 2025 - Clinical-stage immunotherapeutics company Aqualung Therapeutics announced on Monday that it has received approval from the US Food and Drug Administration (FDA) for a Phase 2a study...
Faron launches BLAZE trial with Institute of Cancer Research to address immunotherapy resistance
22 December 2025 - Finland-based biopharmaceutical company Faron Pharmaceuticals Ltd (AIM:FARN) (First North:FARON) announced on Monday that it has finalised agreements to initiate the Phase I/II BLAZ...
GSK agrees US pricing framework to expand access to respiratory medicines
22 December 2025 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) announced on Monday that it has entered into a voluntary agreement with the US Administration to lower prescription drug pri...